HIGHLIGHTS
- who: Kalyan Pande from the San Francisco, CA, United States, Infectious Disease and Vaccine Discovery, Merck and Co, Inc, West Point, PA, United States University of Georgia, United States have published the paper: Hexamerization of Anti-SARS CoV IgG1 Antibodies Improves Neutralization Capacity, in the Journal: (JOURNAL)
- how: CHO-K1 cells stably expressing either the SARS-CoV-1 or SARS-CoV-2 spike_protein were used in the experiment. Epitope Binding Is Necessary but Not Sufficient for Hexamer Formation To measure the ability of each antibody-epitope pair to form a hexamer the authors employed a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.